vs

Side-by-side financial comparison of N-able, Inc. (NABL) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $130.3M, roughly 1.5× N-able, Inc.). On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 11.8%). N-able, Inc. produced more free cash flow last quarter ($20.9M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 7.0%).

Able UK is a British industrial services company specialising in decommissioning of ships and offshore installations.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

NABL vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.5× larger
RGEN
$197.9M
$130.3M
NABL
Growing faster (revenue YoY)
RGEN
RGEN
+1.8% gap
RGEN
13.6%
11.8%
NABL
More free cash flow
NABL
NABL
$3.3M more FCF
NABL
$20.9M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
7.0%
NABL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NABL
NABL
RGEN
RGEN
Revenue
$130.3M
$197.9M
Net Profit
$13.3M
Gross Margin
76.2%
52.5%
Operating Margin
10.2%
9.0%
Net Margin
6.7%
Revenue YoY
11.8%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$-0.04
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NABL
NABL
RGEN
RGEN
Q4 25
$130.3M
$197.9M
Q3 25
$131.7M
$188.8M
Q2 25
$131.2M
$182.4M
Q1 25
$118.2M
$169.2M
Q4 24
$116.5M
$174.1M
Q3 24
$116.4M
$154.9M
Q2 24
$119.4M
$154.1M
Q1 24
$113.7M
$151.3M
Net Profit
NABL
NABL
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$1.4M
$14.9M
Q2 25
$-4.0M
$14.9M
Q1 25
$-7.2M
$5.8M
Q4 24
$-30.3M
Q3 24
$10.8M
$-654.0K
Q2 24
$9.5M
$3.3M
Q1 24
$7.5M
$2.1M
Gross Margin
NABL
NABL
RGEN
RGEN
Q4 25
76.2%
52.5%
Q3 25
77.5%
53.2%
Q2 25
78.1%
50.0%
Q1 25
76.6%
53.6%
Q4 24
80.0%
26.1%
Q3 24
82.9%
50.0%
Q2 24
84.0%
49.8%
Q1 24
83.9%
49.5%
Operating Margin
NABL
NABL
RGEN
RGEN
Q4 25
10.2%
9.0%
Q3 25
8.8%
8.9%
Q2 25
7.7%
7.6%
Q1 25
1.5%
3.9%
Q4 24
13.7%
-17.7%
Q3 24
20.5%
-5.1%
Q2 24
18.4%
1.0%
Q1 24
18.0%
1.3%
Net Margin
NABL
NABL
RGEN
RGEN
Q4 25
6.7%
Q3 25
1.1%
7.9%
Q2 25
-3.1%
8.2%
Q1 25
-6.1%
3.4%
Q4 24
-17.4%
Q3 24
9.2%
-0.4%
Q2 24
7.9%
2.2%
Q1 24
6.6%
1.4%
EPS (diluted)
NABL
NABL
RGEN
RGEN
Q4 25
$-0.04
$0.24
Q3 25
$0.01
$0.26
Q2 25
$-0.02
$0.26
Q1 25
$-0.04
$0.10
Q4 24
$0.01
$-0.55
Q3 24
$0.06
$-0.01
Q2 24
$0.05
$0.06
Q1 24
$0.04
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NABL
NABL
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$111.8M
$767.6M
Total DebtLower is stronger
$393.9M
$542.2M
Stockholders' EquityBook value
$804.7M
$2.1B
Total Assets
$1.4B
$2.9B
Debt / EquityLower = less leverage
0.49×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NABL
NABL
RGEN
RGEN
Q4 25
$111.8M
$767.6M
Q3 25
$101.4M
$748.7M
Q2 25
$93.9M
$708.9M
Q1 25
$94.1M
$697.2M
Q4 24
$85.2M
$757.4M
Q3 24
$174.4M
$784.0M
Q2 24
$157.5M
$809.1M
Q1 24
$139.2M
$780.6M
Total Debt
NABL
NABL
RGEN
RGEN
Q4 25
$393.9M
$542.2M
Q3 25
$331.7M
$537.9M
Q2 25
$332.1M
Q1 25
$332.6M
Q4 24
$333.1M
$525.6M
Q3 24
$333.6M
Q2 24
$334.1M
Q1 24
$334.5M
Stockholders' Equity
NABL
NABL
RGEN
RGEN
Q4 25
$804.7M
$2.1B
Q3 25
$813.4M
$2.1B
Q2 25
$809.4M
$2.1B
Q1 25
$775.1M
$2.0B
Q4 24
$759.3M
$2.0B
Q3 24
$765.0M
$2.0B
Q2 24
$724.4M
$2.0B
Q1 24
$709.1M
$2.0B
Total Assets
NABL
NABL
RGEN
RGEN
Q4 25
$1.4B
$2.9B
Q3 25
$1.4B
$2.9B
Q2 25
$1.4B
$2.9B
Q1 25
$1.4B
$2.9B
Q4 24
$1.3B
$2.8B
Q3 24
$1.2B
$2.8B
Q2 24
$1.2B
$2.9B
Q1 24
$1.1B
$2.8B
Debt / Equity
NABL
NABL
RGEN
RGEN
Q4 25
0.49×
0.26×
Q3 25
0.41×
0.26×
Q2 25
0.41×
Q1 25
0.43×
Q4 24
0.44×
0.27×
Q3 24
0.44×
Q2 24
0.46×
Q1 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NABL
NABL
RGEN
RGEN
Operating Cash FlowLast quarter
$25.3M
$25.7M
Free Cash FlowOCF − Capex
$20.9M
$17.6M
FCF MarginFCF / Revenue
16.0%
8.9%
Capex IntensityCapex / Revenue
3.4%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$75.1M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NABL
NABL
RGEN
RGEN
Q4 25
$25.3M
$25.7M
Q3 25
$24.0M
$48.1M
Q2 25
$24.2M
$28.6M
Q1 25
$19.7M
$15.0M
Q4 24
$26.0M
$39.2M
Q3 24
$22.0M
$49.3M
Q2 24
$27.3M
$42.2M
Q1 24
$4.2M
$44.7M
Free Cash Flow
NABL
NABL
RGEN
RGEN
Q4 25
$20.9M
$17.6M
Q3 25
$17.4M
$43.4M
Q2 25
$20.4M
$21.5M
Q1 25
$16.4M
$11.4M
Q4 24
$18.8M
$33.6M
Q3 24
$18.2M
$42.3M
Q2 24
$24.0M
$37.4M
Q1 24
$746.0K
$36.4M
FCF Margin
NABL
NABL
RGEN
RGEN
Q4 25
16.0%
8.9%
Q3 25
13.2%
23.0%
Q2 25
15.5%
11.8%
Q1 25
13.9%
6.8%
Q4 24
16.2%
19.3%
Q3 24
15.7%
27.3%
Q2 24
20.1%
24.3%
Q1 24
0.7%
24.0%
Capex Intensity
NABL
NABL
RGEN
RGEN
Q4 25
3.4%
4.1%
Q3 25
5.0%
2.5%
Q2 25
2.9%
3.9%
Q1 25
2.8%
2.1%
Q4 24
6.1%
3.2%
Q3 24
3.2%
4.5%
Q2 24
2.7%
3.1%
Q1 24
3.0%
5.5%
Cash Conversion
NABL
NABL
RGEN
RGEN
Q4 25
1.93×
Q3 25
17.36×
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
2.04×
Q2 24
2.89×
12.70×
Q1 24
0.56×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NABL
NABL

Transferred Over Time$121.9M94%
Transferred At Point In Time$8.4M6%
Other Revenue$1.3M1%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons